GLSI Greenwich LifeSciences Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: GLSI

Price (delayed)

$14.39

Market cap

$185.32M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.69

Enterprise value

$178.33M

Greenwich LifeSciences is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. GP2 is a ...

Highlights
GLSI's EPS is down by 13% year-on-year but it is up by 2.8% since the previous quarter
The quick ratio has plunged by 54% YoY and by 23% from the previous quarter
The equity fell by 49% YoY and by 24% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://greenwichlifesciences.com
Peers: NVCR NVAX

Key stats

What are the main financial stats of GLSI
Market
Shares outstanding
12.88M
Market cap
$185.32M
Enterprise value
$178.33M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
27.59
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$8.89M
EBITDA
-$8.89M
Free cash flow
-$6.48M
Per share
EPS
-$0.69
Free cash flow per share
-$0.5
Book value per share
$0.52
Revenue per share
$0
TBVPS
$0.54
Balance sheet
Total assets
$6.99M
Total liabilities
$294,406
Debt
$0
Equity
$6.7M
Working capital
$6.7M
Liquidity
Debt to equity
0
Current ratio
23.76
Quick ratio
23.74
Net debt/EBITDA
0.79
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-91.2%
Return on equity
-93.9%
Return on invested capital
N/A
Return on capital employed
-132.7%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GLSI stock price

How has the Greenwich LifeSciences stock price performed over time
Intraday
2.86%
1 week
9.68%
1 month
-18.79%
1 year
25.02%
YTD
36.79%
QTD
-27.83%

Financial performance

How have Greenwich LifeSciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$9.33M
Net income
-$8.89M
Gross margin
N/A
Net margin
N/A
The operating income has declined by 16% year-on-year
The net income has contracted by 14% YoY

Growth

What is Greenwich LifeSciences's growth rate over time

Valuation

What is Greenwich LifeSciences stock price valuation
P/E
N/A
P/B
27.59
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
GLSI's EPS is down by 13% year-on-year but it is up by 2.8% since the previous quarter
GLSI's P/B is 84% higher than its last 4 quarters average of 15.0
The equity fell by 49% YoY and by 24% QoQ

Efficiency

How efficient is Greenwich LifeSciences business performance
The return on equity has dropped by 95% year-on-year and by 17% since the previous quarter
The ROA has shrunk by 92% YoY and by 16% QoQ

Dividends

What is GLSI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GLSI.

Financial health

How did Greenwich LifeSciences financials performed over time
The current ratio has plunged by 54% YoY and by 23% from the previous quarter
The quick ratio has plunged by 54% YoY and by 23% from the previous quarter
The company's debt is 100% lower than its equity
The equity fell by 49% YoY and by 24% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.